Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension



Rating:

Share or cite this content

Citations should be made in the following way:
K. Golebski (Amsterdam, Netherlands), M. Gorenjak (Maribor, Slovenia), M. Kabesch (Regensburg, Germany), A. Maitland-Van Der Zee (Amsterdam, Netherlands), E. Melén (Stockholm, Sweden), U. Potocnik (Maribor, Slovenia), S. Reinartz (Hilversum, Netherlands), E. Santos Valente (Regensburg, Germany), S. Vijverberg (Amsterdam, Netherlands), C. Van Drunen (Amsterdam, Netherlands). EGR-1 as a potential biomarker in asthma and proinflammatory responses in airway epithelium. 2041

Member's Comments

No comment yet.

Related content which might interest you: A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 IL-25 secreted from epithelial cells has the potential to promote airway remodeling in asthma Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Evidence for secretion of IL-18 in asthmatic airway inflammation assessed by endobronchial allergen challenge and its relationship to accumulation of inflammatory cells Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001 The role of the COPD susceptibility gene FAM13A in barrier function and pro-inflammatory responses of human airway epithelial cells Source: ERS Lung Science Conference 2020 Year: 2020 Role of IL-33 signaling in pollutant-induced allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung Year: 2013 A potential role of P2X7R in allergic airway inflammation Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 High-level expression of PD-L1 by DC suppresses airway inflammation in OVA-induced allergic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Airway epithelial cell P2Y6R-Expression is up-regulated during acute and chronic allergic inflammation and contributes via modulating of CXC8 and IL-6 secretion to development of airway remodelling Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010 Interleukin-17A activation on bronchial epithelium and basophils: a novel inflammatory mechanism Source: Eur Respir J 2010; 35: 883-893 Year: 2010 Anti-cytokine approaches should target bronchial hyperresponsiveness rather than inflammation – Pro Source: Annual Congress 2006 - Pro/Con: asthma is (not) an inflammatory disease Year: 2006 Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation and remodelling Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007 Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients Source: Annual Congress 2009 - Pathology and immunology of COPD Year: 2009 Transgenic mice overexpressing IL-18 display increased IL-13 in the airways but no changes of the airway hyperresponsiveness in a murine model of late-phase asthma: evidence for a dual role of IL-18 on mucosal Th1/Th2 responses Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002 The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 Caveolin-1 expression in airway smooth muscle cells is related to airway responsiveness magnitude in allergic asthma model Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology Year: 2011 Airway fibroblasts phenotype markers after pro-inflammatory cytokines challenge Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 Imiquimod attenuate airway inflammation and decrease the expression of TARC in allergic asthmatic mice Source: Eur Respir J 2006; 28: Suppl. 50, 224s Year: 2006 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 Over-expression of Th17-related cytokines in bronchial and nasal submucosa in severe asthma Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012